Evaluation of Brain FDG-PET as Part of a Complete Medical Checkup

Evaluation of Brain FDG-PET as Part of a Complete Medical Checkup - BrainFDG-PET in Medical Checkup

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013631

Enrollment

100

Registered

2014-04-04

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study population will consist of people who have a special cancer screening (whole-body FDG-PET) at the Preventive Medicine Center and consent to undergo cognitive function tests and brain FDG-PET.

Exclusion criteria

Exclusion criteria: Disagree

Design outcomes

Primary

Measure	Time frame
Each 30 subjects who have abnormal metabolism on an FDG-PET scan will be monitored for a long term to assess changes in clinical features and cognitive function over time.	—

Countries

Japan

Contacts

Public ContactDaisuke Ito

School of medicine, Keio University Department of neurology

dito@z8.keio.jp03-5363-3788

Outcome results